110 related articles for article (PubMed ID: 18260957)
1. [Influence of valsartan, fluvastatin extended release and their combination on arterial pressure, parameters of lipid metabolism, and endothelial function in patients with hypertensive disease].
Soboleva GN; Pogorelova OA; Kuznetsova TV; Masenko VP; Fomicheva OA; Chernova NA; Rogoza AN; Balakhonova TV; Karpov IuA
Kardiologiia; 2007; 47(11):9-13. PubMed ID: 18260957
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.
Horiuchi M; Cui TX; Li Z; Li JM; Nakagami H; Iwai M
Circulation; 2003 Jan; 107(1):106-12. PubMed ID: 12515751
[TBL] [Abstract][Full Text] [Related]
3. Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
Ruggenenti P; Perna A; Tonelli M; Loriga G; Motterlini N; Rubis N; Ledda F; Rota S; Satta A; Granata A; Battaglia G; Cambareri F; David S; Gaspari F; Stucchi N; Carminati S; Ene-Iordache B; Cravedi P; Remuzzi G;
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1928-38. PubMed ID: 20671225
[TBL] [Abstract][Full Text] [Related]
4. Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: studies in hypercholesterolemic and hypertensive patients.
Hussein O; Shneider J; Rosenblat M; Aviram M
J Cardiovasc Pharmacol; 2002 Jul; 40(1):28-34. PubMed ID: 12072574
[TBL] [Abstract][Full Text] [Related]
5. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.
Lunder M; Janić M; Jug B; Sabovič M
Eur J Intern Med; 2012 Apr; 23(3):261-6. PubMed ID: 22385885
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
7. Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.
Savić V; Eržen B; Janić M; Lunder M; Boncelj M; Kanc K; Janež A; Šabović M
Diab Vasc Dis Res; 2013 Sep; 10(5):420-5. PubMed ID: 23811602
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis.
Li Z; Iwai M; Wu L; Liu HW; Chen R; Jinno T; Suzuki J; Tsuda M; Gao XY; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 Nov; 44(5):758-63. PubMed ID: 15452025
[TBL] [Abstract][Full Text] [Related]
9. Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
Boncelj Svetek M; Eržen B; Kanc K; Šabovič M
J Diabetes Complications; 2017 Mar; 31(3):544-550. PubMed ID: 28012835
[TBL] [Abstract][Full Text] [Related]
10. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
11. Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus.
Lunder M; Janić M; Savić V; Janež A; Kanc K; Šabovič M
Diabetes Res Clin Pract; 2017 May; 127():181-186. PubMed ID: 28384560
[TBL] [Abstract][Full Text] [Related]
12. Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient.
Kosch M; Barenbrock M; Suwelack B; Schaefer RM; Rahn KH; Hausberg M
Am J Kidney Dis; 2003 May; 41(5):1088-96. PubMed ID: 12722044
[TBL] [Abstract][Full Text] [Related]
13. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients.
Nakamura T; Fujii S; Hoshino J; Saito Y; Mizuno H; Saito Y; Kurabayashi M
Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331
[TBL] [Abstract][Full Text] [Related]
14. Different galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction.
Westphal S; Abletshauser C; Luley C
Coron Artery Dis; 2009 Jan; 20(1):81-5. PubMed ID: 19060628
[TBL] [Abstract][Full Text] [Related]
15. Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.
Qi WW; Liu T; Xu G; Li LF; Liang YZ; Ye L; Li GP
Trials; 2015 Aug; 16():336. PubMed ID: 26248619
[TBL] [Abstract][Full Text] [Related]
16. Effect of add-on aliskiren to type 1 angiotensin receptor blocker therapy on endothelial function and autonomic nervous system in hypertensive patients with ischemic heart disease.
Ozeki A; Amiya E; Watanabe M; Hosoya Y; Takata M; Watanabe A; Kawarasaki S; Nakao T; Watanabe S; Omori K; Yamada N; Tahara Y; Hirata Y; Nagai R
J Clin Hypertens (Greenwich); 2014 Aug; 16(8):591-8. PubMed ID: 25039889
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension.
Okura T; Watanabe S; Kurata M; Koresawa M; Irita J; Enomoto D; Jotoku M; Miyoshi K; Fukuoka T; Higaki J
Clin Exp Hypertens; 2008 Jul; 30(5):415-22. PubMed ID: 18633763
[TBL] [Abstract][Full Text] [Related]
18. Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels.
Schneider MP; Schmidt BM; John S; Schmieder RE
J Hypertens; 2011 Sep; 29(9):1757-64. PubMed ID: 21799442
[TBL] [Abstract][Full Text] [Related]
19. A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males.
Janić M; Lunder M; Prezelj M; Šabovič M
J Cardiopulm Rehabil Prev; 2014; 34(3):208-12. PubMed ID: 24263076
[TBL] [Abstract][Full Text] [Related]
20. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.
Anan F; Takahashi N; Ooie T; Yufu K; Hara M; Nakagawa M; Yonemochi H; Saikawa T; Yoshimatsu H
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):353-9. PubMed ID: 15918057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]